Jessica Hammett
Neurology · Jacksonville, FLNPI 1629778360
Payments from drug & device makers
Across 287 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$685
- AbbVie$605
- Novartis$557
- Eisai Inc.$552
- Lundbeck LLC$451
- Argenx US, Inc.$394
- plus $3K from 26 others
What the payments were for
- Consulting fees$2253%
- Food & beverage$6,24795%
- Education$811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 28 | $685 |
| AbbVie | 28 | $605 |
| Novartis | 31 | $557 |
| Eisai Inc. | 20 | $552 |
| Lundbeck LLC | 18 | $451 |
| Argenx US, Inc. | 15 | $394 |
| UCB, Inc. | 15 | $388 |
| Teva Pharmaceuticals USA, Inc. | 23 | $347 |
| Pfizer | 21 | $299 |
| SK Life Science, Inc. | 9 | $253 |
| AstraZeneca(2 entities) | 10 | $243 |
| Boston Scientific | 1 | $225 |
| Amneal Pharmaceuticals LLC | 10 | $217 |
| Genentech USA, Inc. | 6 | $145 |
| Otsuka America Pharmaceutical, Inc. | 7 | $142 |
| Axsome Therapeutics, Inc. | 8 | $140 |
| Kyowa Kirin, Inc. | 7 | $135 |
| Mallinckrodt Hospital Products Inc. | 4 | $118 |
| Amgen | 3 | $98 |
| Medtronic | 4 | $79 |
| Biogen | 2 | $59 |
| Tanabe Pharma America, Inc. | 2 | $54 |
| MDD US Operations, LLC | 1 | $49 |
| Impel Pharmaceuticals LLC | 2 | $49 |
| Microtransponder, Inc. | 1 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $43 |
| EMD Serono, Inc. | 2 | $43 |
| Neurelis, Inc. | 2 | $42 |
| Acadia Pharmaceuticals Inc | 2 | $35 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$225
- Leqembi$125
- KISUNLA$122
How this compares
$6,554 in reported general payments places this provider in the 60th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 30 | $38,933 |
| Aimovig AutoinjectorErenumab-Aooe | 26 | $20,127 |
| Emgality PenGalcanezumab-Gnlm | 26 | $17,738 |
| QuliptaAtogepant | 16 | $17,248 |
| Dimethyl Fumarate | 13 | $2,352 |
| Memantine Hcl | 136 | $1,867 |
| Gabapentin | 152 | $819 |
| Primidone | 38 | $715 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 59 | $626 |
| Donepezil Hcl | 113 | $619 |
| Propranolol Hcl ErPropranolol Hcl | 14 | $606 |
| Topiramate | 66 | $521 |
| Levetiracetam | 28 | $521 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 13 | $382 |
| Propranolol Hcl | 25 | $318 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $605 | $56,18146 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,434 neurology providers in Florida.
Other neurology in Jacksonville
- Steven ToenjesJacksonville$6.9M
- Neill Graff-RadfordJacksonville$2.6M
- Bjorn OskarssonJacksonville$2.3M
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.